KINGWOOD, Texas, Feb. 12 /PRNewswire-FirstCall/ -- International Merchant Advisors, Inc. (Pink Sheets: IMAI) announced today that the company has formally offered to purchase an equity position in a pharmaceutical operation that is focused on selling in the chronic pain management medical sector. The pharmaceutical company has gross revenues in eight figures, but will not be identified until IMAI has a signed letter of intent from the company for the proposed investment transaction.
Mel Roseman, CEO commented, "We recently announced our intention to enter the healthcare services sector, with a particular interest in chronic pain management and wellness centers. With the advent of healthcare reform and continuing pressure on reimbursements from Medicare, Medicaid, and insurance companies, we believe alternative, lower cost wellness centers have great promise. Just today, the Obama Administration Health and Human Services Secretary Kathleen Sebelius criticized Wellpoint, Inc. for its proposed 38% increase in premiums for Californians even though Wellpoint just released earnings in excess of $2 billion. The market is looking for more efficient and less expensive healthcare solutions, and we believe this is a part of that solution demanded by the market.
About International Merchant Advisors, Inc.
International Merchant Advisors, Inc. (IMAI) is an international business banker and builder of companies. IMAI provides direct access to the critical tools necessary to satisfy the growth requirements of international emerging and re-emerging public and private companies. These tools include providing strategic advisory services, capital raising strategies, direct access to capital markets, and organizational development and business plan execution.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report.
SOURCE International Merchant Advisors, Inc.
|SOURCE International Merchant Advisors, Inc.|
Copyright©2010 PR Newswire.
All rights reserved